Company / Interest Expense
West Pharmaceutical Services Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$15.1M
FY2025
5-year range
$8.2M / $16.2M
FY2021-FY2025
Trend
-6.8%
vs FY2024
Sector context
#34 of 44
Health Care
What the data says
West Pharmaceutical Services's interest expense of $15M is lower than 77% of companies in the Health Care sector (FY2025). Interest Expense has fluctuated over the past 10 years, ranging from $8M in FY2017 to $17M in FY2016.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of +12.4%.
Increased from $9M to $15M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +22.6%
- 5-Year CAGR
- +12.4%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 44This company $15.1M Sector average $316.9M
▼
-95.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.4%, indicating consistent growth.
- In FY2025, interest expense decreased 6.8% year-over-year.
- Ranks #34 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.1M | -6.8% |
| FY2024 | $16.2M | +80.0% |
| FY2023 | $9.0M | +9.8% |
| FY2022 | $8.2M | -3.5% |
| FY2021 | $8.5M | +1.2% |
| FY2020 | $8.4M | -1.2% |
| FY2019 | $8.5M | +1.2% |
| FY2018 | $8.4M | +7.7% |
| FY2017 | $7.8M | -52.7% |
| FY2016 | $16.5M | -2.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026